A novel method for preparing menstrual blood mesenchymal stem cells
A technology of mesenchymal stem cells and menstrual blood, applied in the field of biomedicine, to achieve the effects of avoiding damage, strong uniformity, and high cell density
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0075] Example 1 In vitro collection of blood
[0076] The urine cup is used to collect menstrual blood outside the body. The main process is as follows:
[0077] Before that, the menstrual blood was collected in the body. This method not only has certain requirements for the volunteers, such as married women, but also has certain damage to the volunteers’ bodies. Our method is to collect them outside the body, that is, There are no strict requirements for volunteers. This method requires the volunteers to collect when the menstrual blood flow is relatively large. During the menstrual period, the volunteers save for a period of time when they are less active. Use a disposable urine collection cup (such as figure 1 shown) at room temperature for collection, pour the collected menstrual blood into a screw-cap collection tube with a scale on the tube wall and containing 25ml of menstrual blood collection fluid (capacity is 50ml, figure 2 ), you need to collect about 20ml of me...
Embodiment 2
[0079] Example 2 Isolation of mesenchymal stem cells from menstrual blood (centrifugation)
[0080] The mixture of menstrual blood sample and collection fluid was filtered with a 100 μm cell strainer (brand: BD; product number: 352360) to remove most mucus and clots, and then mononuclear cells were collected by density gradient centrifugation. Mononuclear cells were counted with a hemocytometer.
[0081] Mononuclear cells are collected and subjected to cell expansion, purification and cryopreservation.
[0082]1. The filtered menstrual blood sample is obtained by density gradient centrifugation to obtain mononuclear cells: slowly add the sample to the human lymphocyte separation medium (TBD), and the volume ratio of the sample to the TBD separation medium is 2:1. Centrifuge at 800g for 15 minutes in a tabletop centrifuge.
[0083] 2. Absorb the central buffy coat cells, that is, mononuclear cells, into another clean centrifuge tube, add PBS and repeat centrifugal washing for...
Embodiment 4
[0110] Example 4 The tumorigenicity of menstrual blood mesenchymal stem cells separated by the present invention
[0111] 64 nude mice were divided into the positive control group and the mesenchymal stem cell group obtained in Example 2, 32 in each group, half male and half male. The mesenchymal stem cells obtained in Example 2 at the fifth passage were inoculated into nude mice subcutaneously, and 5×10 6 Menstrual blood stem cells and gastric cancer BGC823 cell line. The experimental observation time ranged from 2 weeks to 2 months, and none of the test groups inoculated with menstrual blood stem cells of the present invention had tumorigenicity. Exemplary results such as Figure 5 Shown (observation results after four weeks of inoculation), where the upper picture is menstrual blood stem cells (5 × 10 6 cells); the figure below is gastric cancer cell line BGC823 (5×10 6 cell).
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com